Literature DB >> 6830210

Penicillin therapy of experimental endocarditis induced by tolerant Streptococcus sanguis and nontolerant Streptococcus mitis.

F D Lowy, E G Neuhaus, D S Chang, N H Steigbigel.   

Abstract

The response of tolerant Streptococcus sanguis and nontolerant Streptococcus mitis infections to penicillin therapy was compared in the rabbit model of endocarditis. The minimal inhibitory and bactericidal concentrations of penicillin were 0.1 and 0.1 mug/ml, respectively, for S. mitis and 0.05 and 6.2 mug/ml, respectively, for S. sanguis. Time-kill studies done in vitro with penicillin concentrations of 2 and 20 mug/ml demonstrated minimal killing of the tolerant strain, with a 3 log difference in survival between the two strains after 24 and 48 h. Both strains produced endocarditis with comparable bacterial densities on the valvular vegetations. Rabbits were treated with procaine penicillin G in two dosage regimens, 80,000 or 5,000 U/kg given every 8 h. There was no difference between bacterial densities in valvular vegetations removed from rabbits infected with either strain after 2, 4, or 6 days of treatment with the high-dose regimen (serum penicillin concentration at 0.5 h, 9.4 mug/ml), despite the fact that serum bactericidal activity against the tolerant strain at 0.5 h was minimal. With the low-dose penicillin regimen (serum concentration at 0.5 h, 2.5 mug/ml), therapy was significantly less effective in the tolerant group only after 6 days of treatment. Similar results were obtained when penicillin was administered in low and high doses to prevent infection. In this animal model of infection, penicillin tolerance was associated with a diminished response to penicillin therapy only when the dose was severely restricted. In the high-dose regimen, there was no difference in the response to penicillin therapy between animals infected with either strain, despite the presence of only minimal serum bactericidal activity in the rabbits infected with the tolerant strain.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6830210      PMCID: PMC184619          DOI: 10.1128/AAC.23.1.67

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Infective endocarditis caused by Streptococcus bovis resistant to the lethal effect of penicillin G.

Authors:  C B Savitch; A L Barry; P D Hoeprich
Journal:  Arch Intern Med       Date:  1978-06

2.  Tolerant response of Streptococcus sanguis to beta-lactams and other cell wall inhibitors.

Authors:  D Horne; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

3.  Incidence and characteristics of antibiotic-tolerant strains of Staphylococcus aureus.

Authors:  J J Bradely; C G Mayhall; H P Dalton
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

4.  Release of lipoteichoic acid from Streptococcus sanguis: stimulation of release during penicillin treatment.

Authors:  D Horne; A Tomasz
Journal:  J Bacteriol       Date:  1979-03       Impact factor: 3.490

5.  Multiple antibiotic resistance in a bacterium with suppressed autolytic system.

Authors:  A Tomasz; A Albino; E Zanati
Journal:  Nature       Date:  1970-07-11       Impact factor: 49.962

6.  Rapid microassay of gentamicin, kanamycin, neomycin, streptomycin, and vancomycin in serum or plasma.

Authors:  L D Sabath; J I Casey; P A Ruch; L L Stumpf; M Finland
Journal:  J Lab Clin Med       Date:  1971-09

7.  Significance of methicillin tolerance in experimental staphylococcal endocarditis.

Authors:  P L Goldman; R G Petersdorf
Journal:  Antimicrob Agents Chemother       Date:  1979-06       Impact factor: 5.191

8.  Medium-dependent variation in bactericidal activity of antibiotics against susceptible Staphylococcus aureus.

Authors:  L R Peterson; D N Gerding; W H Hall; E A Schierl
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

9.  A new type of penicillin resistance of Staphylococcus aureus.

Authors:  L D Sabath; N Wheeler; M Laverdiere; D Blazevic; B J Wilkinson
Journal:  Lancet       Date:  1977-02-26       Impact factor: 79.321

10.  Persistent bacteremia in staphylococcal endocarditis.

Authors:  M T Reymann; H P Holley; C G Cobbs
Journal:  Am J Med       Date:  1978-11       Impact factor: 4.965

View more
  6 in total

1.  Discrepancies between MBC and actual killing of viridans group streptococci by cell-wall-active antibiotics.

Authors:  P R Meylan; P Francioli; M P Glauser
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191

Review 2.  Antibiotic tolerance among clinical isolates of bacteria.

Authors:  E Tuomanen; D T Durack; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

Review 3.  Problems in in vitro determination of antibiotic tolerance in clinical isolates.

Authors:  J C Sherris
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

4.  In vitro development and stability of tolerance to cloxacillin and vancomycin in Staphylococcus aureus.

Authors:  G P Voorn; J Thompson; W H Goessens; W C Schmal-Bauer; P H Broeders; M F Michel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-09       Impact factor: 3.267

5.  Penicillin-induced effects on streptomycin uptake and early bactericidal activity differ in viridans group and enterococcal streptococci.

Authors:  M H Miller; M A el-Sokkary; S A Feinstein; F D Lowy
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

6.  Distribution, antibiotic susceptibility and tolerance of bacterial isolates in culture-positive cases of endocarditis in The Netherlands.

Authors:  J T van der Meer; W van Vianen; E Hu; W B van Leeuwen; H A Valkenburg; J Thompson; M F Michel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-09       Impact factor: 3.267

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.